Stroke, Acute: Clinical Trials

4 trials for Stroke, Acute, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow Stroke, Acute: new trials by email Literature Review of Stroke, Acute trials Research Report on Stroke, Acute

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Insulin for Hyperglycemia in Stroke Trial
Analog Insulin, Human insulin - Hyperglycemia, Stroke, Acute
Phase 4CompletedNational Institute of Neurosciences and Hospital, Dhaka4522021-04-052021-12-06
A Phase 4 Clinical Study to Investigate the Efficacy and Safety of Naloxone HCI IV in Patients With Stroke
Naloxone hydrochloride 5.0mg/5ml, Sodium Chloride 45mg/5ml - Stroke, Acute
Phase 4CompletedSamjin Pharmaceutical Co., Ltd.4462018-08-072023-08-14
Human Urinary Kallidinogenase Improve Short Term Motor Functional Outcome of Acute Ischemia Stroke Patients
Kallikrein - Stroke, Acute
Phase 4CompletedThe Second Hospital of Hebei Medical University802017-07-012021-03-01
Stroke Treatment With Acute Reperfusion and Simvastatin
Simvastatin - Stroke, Acute
Phase 4CompletedHospital Universitari Vall d'Hebron Research Institute1042009-04-012016-12-21

Narrower conditions

Stroke (4)  ·  Cerebral Infarction (1)  ·  Hyperglycemia (1)  ·  Insulin Resistance (1)

Broader conditions

Brain Diseases (4)  ·  Cardiovascular Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Cerebrovascular Disorders (4)  ·  Nervous System Diseases (4)  ·  Vascular Diseases (4)  ·  Brain Infarction (1)  ·  Brain Ischemia (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Infarction (1)  ·  Ischemia (1)  ·  Metabolic Diseases (1)  ·  Necrosis (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Insulin (1)  ·  Insulin Aspart (1)  ·  Insulin Glargine (1)  ·  Insulin, Isophane (1)  ·  Kallikreins (1)  ·  Naloxone (1)  ·  Simvastatin (1)  ·  Sodium Chloride (1)

Sponsors

Hospital Universitari Vall d'Hebron Research Institute (1)  ·  National Institute of Neurosciences and Hospital, Dhaka (1)  ·  Samjin Pharmaceutical Co., Ltd. (1)  ·  The Second Hospital of Hebei Medical University (1)

Countries

Bangladesh (1)  ·  China (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Carmen Jimenez, MD (1)  ·  David Canovas, MD (1)  ·  Dong Keun Hyun, M.D.,Ph.D (1)  ·  Francisco Alonso, MD, PhD (1)  ·  Francisco Rubio Borrego, MD, PhD (1)  ·  Joan Montaner, MD, PhD (1)  ·  Jose Manuel Flores, MD (1)  ·  Juan Arenillas, MD, PhD (1)  ·  Jurek Krupinski, MD (1)

Results publications

PMID 27758944, PMID 31334795, PMID 38526971